Moreover, immunotherapy is assumed to elicit an anti-tumor response, PD-1 and CTLA-4 inhibition have shown significant effectiveness in treating several solid cancers, such as melanoma and lung cancer (20–22). This evidence concerns the gene PDCD1 and neoplasm.